| Number | Sex/age (years) | Symptoms/signs | Tumor localization | Treatment modality | Survival and outcome (months) |
| 1 | F/18 | Palpable abdominal mass, distention | Mesentery pelvic cavity | Biopsy, chemotherapy | 7 | 2 | M/14 | Pain, vomiting palpable mass | Omentum mesentery pelvic | Biopsy, chemotherapy | 9 | 3 | M/23 | Abdominal pain, urinary retention | Colon, pelvic concurrent metastasis | Biopsy, chemotherapy | 11 | 4 | M/18 | Vomiting, palpable mass | Mesentery, abdomen, involving liver. | Biopsy, chemotherapy | 11 | 5 | M/38 | Abdominal pain distention | Mesentery, intestines | Biopsy, chemotherapy | 12 | 6 | M/54 | Vomiting | Intestines, mesentery | Unresectable, chemotherapy | 37 | 7 | F/18 | Abdominal pain, palpable mass | Retroperitoneum, abdomen | Multiple-organ en bloc resection chemotherapy | 13 | 8 | F/16 | Vomiting | Omental and serosal surfaces | Surgery complete chemotherapy | 22 | 9 | M/24 | Nausea, palpable mass | Intestines, pelvis, and retroperitoneum | Debulking surgery, chemotherapy | 24 | 10 | F/26 | Abdominal distention | Abdomen, retroperitoneum | Surgery (microresiduals), chemotherapy | 36 | 11 | M/21 | Abdominal pain, hydronephrosis | Widespread abdomen, peritoneum | Cytoreductive surgery, chemotherapy | 40 | 12 | M/39 | No symptom | Omentum | Complete resection, chemotherapy | Followup 36, no evidence of disease |
|
|